Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Interventional × Toremifene × Clear all

Phase

Status

Sponsor Class

OTHER 14 INDUSTRY 7 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Desmoid Tumors 1

Interventions

Cyclophosphamide 331 Specimen Handling 309 Magnetic Resonance Spectroscopy 267 Radiotherapy 264 Biopsy 229 Cisplatin 216 Carboplatin 204 Doxorubicin 190 Paclitaxel 186 Fluorouracil 173 Etoposide 171 Vincristine 158 Bevacizumab 153 Filgrastim 150 Gemcitabine 139 Leucovorin 130 Cytarabine 128 aldesleukin 120 Docetaxel 103 fludarabine phosphate 98 Rituximab 96 Taxes 95 Oxaliplatin 95 Chemotherapy, Adjuvant 95 Prednisone 89 Irinotecan 89 Radiation 88 Methotrexate 87 Bortezomib 87 Dexamethasone 85

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00002595 2013-07-10

Toremifene in Treating Patients With Desmoid Tumors

National Cancer Institute (NCI)

Phase 2 Completed

Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡